Search

Your search keyword '"Viswanathan, Akila N."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Viswanathan, Akila N." Remove constraint Author: "Viswanathan, Akila N." Topic endometrial neoplasms Remove constraint Topic: endometrial neoplasms
30 results on '"Viswanathan, Akila N."'

Search Results

1. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.

2. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

3. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.

4. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.

5. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older.

6. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.

7. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.

8. The risk of lymphedema after postoperative radiation therapy in endometrial cancer.

9. Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer.

10. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.

11. Rectal bleeding after radiation therapy for endometrial cancer.

12. Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer.

13. Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.

14. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline.

15. Radiation dose escalation using intensity modulated radiation therapy for gross unresected node-positive endometrial cancer.

16. A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.

17. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.

18. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.

19. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.

20. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.

21. Combined chemotherapy and radiation improves survival for node-positive endometrial cancer.

22. Circulating melatonin and the risk of breast and endometrial cancer in women.

23. Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

24. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.

25. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.

26. Night shift work and the risk of endometrial cancer.

27. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.

28. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study.

29. NRG ONCOLOGY/RTOG 0921: A PHASE II STUDY OF POSTOPERATIVE INTENSITY MODULATED RADIATION THERAPY (IMRT) WITH CONCURRENT CISPLATIN AND BEVACIZUMAB FOLLOWED BY CARBOPLATIN AND PACLITAXEL FOR PATIENTS WITH ENDOMETRIAL CANCER

30. Involution of latent endometrial precancers by hormonal and non hormonal mechanisms

Catalog

Books, media, physical & digital resources